Drug Approval | July 26, 2023
Lupin receives approval from TGA Australia for Tiotropium Dry Powder
Tiotropium (as bromide monohydrate) 18 micrograms powder for inhalation in capsule
Tiotropium (as bromide monohydrate) 18 micrograms powder for inhalation in capsule
Apollo Transplant program is the first program in India to cross the landmark of 18500 kidney transplants, 4300 liver transplants and 500 pediatric liver transplants
The launch of HULIO in the United States is an important milestone for Biocon Biologics
Augnito’s AI comprehends all English accents with 99% accuracy
Application being reviewed under the FDA Project Orbis framework, which enables concurrent reviews among US, Australia, Canada, Switzerland, Singapore and United Kingdom health authorities
Survey of Unmet Needs in chronic myeloid leukemia (CML SUN) data signal need for amplified patient voice during treatment discussions that balance quality of life (QoL), efficacy, and tolerability goals across all lines of therapy
Acquisition accelerates Cosette’s women’s health portfolio; with a differentiated, commercial stage, patent protected product
In Phase 3 CCTG IND.227/KEYNOTE-483 trial, KEYTRUDA plus chemotherapy also demonstrated statistically significant improvements in PFS and ORR compared to chemotherapy alone
Suven Life Sciences completed enrollment of patients to the phase-2, PoC clinical study of samelisant (SUVN-G3031) for the treatment of narcolepsy with or without cataplexy in USA and Canada
Tremelimumab in combination with Durvalumab is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC)
Subscribe To Our Newsletter & Stay Updated
